Inflammation and prostate carcinogenesis (Q38031257)

27 August 2017

0 references

Inflammation and prostate carcinogenesis (English)

1 reference

27 August 2017

1 reference

Yasutomo Nakai

1 reference

27 August 2017

Norio Nonomura

series ordinal

1 reference

27 August 2017

publication date

31 July 2012

1 reference

International Journal of Urology

27 August 2017

1 reference

inferred from page(s)

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

150-160

1 reference

The multiethnic cohort study: exploring genes, lifestyle and cancer risk

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Epidemiologic association between prostatitis and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Correlates and prevalence of prostatitis in a large community-based cohort of older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Epidemiological study of prostatic cancer by matched-pair analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Vasectomy and prostate cancer: a case-control study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prostatitis as a risk factor for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sexually transmissible infections and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prostate carcinogenesis and inflammation: emerging insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Epidemiology of inflammation and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-captur

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

NIH consensus definition and classification of prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Chronic prostatitis: epidemiology and role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prostate Histopathology of NIH Category IV Prostatitis Detected by Sextant Prostate Needle Biopsy from the Patients with High Prostatic Specific Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Medical history and etiology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Baseline prostate-specific antigen testing at a young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Meta-analysis of measures of sexual activity and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sexual behaviour, STDs and risks for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Chlamydial antibodies and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sexually transmitted infections and prostate cancer among men in the U.S. military

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sero-epidemiologal association between human-papillomavirus infection and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Human papillomavirus antibody and risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Antibodies against human herpesvirus 8 in black South African patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Correlates of sexually transmitted infection histories in a cohort of American male health professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Acne and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Early growth, adult body size and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Medical history, sexual, and maturational factors and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Implications for RNase L in prostate cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

RETRACTED: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

No Association of Xenotropic Murine Leukemia Virus-Related Viruses with Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

XMRV: A New Virus in Prostate Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Recombinant origin of the retrovirus XMRV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Meat consumption among Black and White men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A prospective study of meat and meat mutagens and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Mutagens, carcinogens, and tumor promoters in our daily food.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A population-based cohort study of mortality among users of ibuprofen in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Regular use of aspirin and prostate cancer risk (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A large cohort study of long-term acetaminophen use and prostate cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Interpretation in drug epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Acne in Adolescence and Cause-specific Mortality: Lower Coronary Heart Disease but Higher Prostate Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

A Working Group Classification of Focal Prostate Atrophy Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

Aspirin and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2012.03101.X

10.1111/J.1442-2042.2012.03101.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference